| Stress-induced changes in miRNA biogenesis and functioning M Olejniczak, A Kotowska-Zimmer, W Krzyzosiak Cellular and molecular life sciences 75, 177-191, 2018 | 142 | 2018 |
| Structural Diversity of Triplet Repeat RNAs*♦ K Sobczak, G Michlewski, M de Mezer, E Kierzek, J Krol, M Olejniczak, ... Journal of Biological Chemistry 285 (17), 12755-12764, 2010 | 136 | 2010 |
| Precise excision of the CAG tract from the huntingtin gene by Cas9 nickases M Dabrowska, W Juzwa, WJ Krzyzosiak, M Olejniczak Frontiers in Neuroscience 12, 75, 2018 | 124 | 2018 |
| Sequence-non-specific effects of RNA interference triggers and microRNA regulators M Olejniczak, P Galka, WJ Krzyzosiak Nucleic acids research 38 (1), 1-16, 2010 | 118 | 2010 |
| Northern blotting analysis of microRNAs, their precursors and RNA interference triggers E Koscianska, J Starega-Roslan, LJ Sznajder, M Olejniczak, ... BMC molecular biology 12, 1-7, 2011 | 80 | 2011 |
| RNA imaging in living cells–methods and applications MO Urbanek, P Galka-Marciniak, M Olejniczak, WJ Krzyzosiak RNA biology 11 (8), 1083-1095, 2014 | 75 | 2014 |
| RAN translation and frameshifting as translational challenges at simple repeats of human neurodegenerative disorders M Wojciechowska, M Olejniczak, P Galka-Marciniak, M Jazurek, ... Nucleic acids research 42 (19), 11849-11864, 2014 | 51 | 2014 |
| Artificial miRNAs as therapeutic tools: Challenges and opportunities A Kotowska‐Zimmer, M Pewinska, M Olejniczak Wiley Interdisciplinary Reviews: RNA 12 (4), e1640, 2021 | 50 | 2021 |
| Computational tools and resources supporting CRISPR-Cas experiments P Sledzinski, M Nowaczyk, M Olejniczak Cells 9 (5), 1288, 2020 | 50 | 2020 |
| An evaluation of oligonucleotide-based therapeutic strategies for polyQ diseases A Fiszer, M Olejniczak, PM Switonski, JP Wroblewska, J Wisniewska-Kruk, ... BMC molecular biology 13, 1-12, 2012 | 48 | 2012 |
| Self-duplexing CUG repeats selectively inhibit mutant huntingtin expression A Fiszer, M Olejniczak, P Galka-Marciniak, A Mykowska, WJ Krzyzosiak Nucleic Acids Research 41 (22), 10426-10437, 2013 | 47 | 2013 |
| Recent advances in understanding of the immunological off-target effects of siRNA M Olejniczak, K Polak, P Galka-Marciniak, W J Krzyzosiak Current gene therapy 11 (6), 532-543, 2011 | 47 | 2011 |
| Genotyping of simple sequence repeat factors implicated in shadow band generation revisited M Olejniczak, WJ Krzyzosiak Electrophoresis 27 (19), 3724-3734, 2006 | 46 | 2006 |
| RNAimmuno: a database of the nonspecific immunological effects of RNA interference and microRNA reagents M Olejniczak, P Galka-Marciniak, K Polak, A Fligier, WJ Krzyzosiak Rna 18 (5), 930-935, 2012 | 41 | 2012 |
| The role of the immune system in triplet repeat expansion diseases M Olejniczak, MO Urbanek, WJ Krzyzosiak Mediators of inflammation 2015, 2015 | 38 | 2015 |
| Universal RNAi triggers for the specific inhibition of mutant huntingtin, atrophin-1, ataxin-3, and ataxin-7 expression A Kotowska-Zimmer, Y Ostrovska, M Olejniczak Molecular Therapy-Nucleic Acids 19, 562-571, 2020 | 30 | 2020 |
| Generation of new isogenic models of Huntington’s disease using CRISPR-Cas9 technology M Dabrowska, A Ciolak, E Kozlowska, A Fiszer, M Olejniczak International journal of molecular sciences 21 (5), 1854, 2020 | 27 | 2020 |
| CAG and CTG repeat polymorphism in exons of human genes shows distinct features at the expandable loci M Rozanska, K Sobczak, A Jasinska, M Napierala, D Kaczynska, ... Human mutation 28 (5), 451-458, 2007 | 26 | 2007 |
| Paving the way towards precise and safe CRISPR genome editing P Sledzinski, M Dabrowska, M Nowaczyk, M Olejniczak Biotechnology Advances 49, 107737, 2021 | 23 | 2021 |
| qEva-CRISPR: a method for quantitative evaluation of CRISPR/Cas-mediated genome editing in target and off-target sites M Dabrowska, K Czubak, W Juzwa, WJ Krzyzosiak, M Olejniczak, ... Nucleic acids research 46 (17), e101-e101, 2018 | 22 | 2018 |
